Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cogstate Limited

Healthcare US COGZF

1.89USD
0.00(0%)

Last update at 2026-06-18T20:00:00Z

Day Range

1.701.70
LowHigh

52 Week Range

0.812.10
LowHigh

Fundamentals

  • Previous Close 1.89
  • Market Cap262.50M
  • Volume500
  • P/E Ratio25.00
  • Dividend Yield0.71%
  • EBITDA13.22M
  • Revenue TTM56.07M
  • Revenue Per Share TTM0.33
  • Gross Profit TTM 31.66M
  • Diluted EPS TTM0.06

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 13.91M 7.10M 3.03M 10.69M 5.82M
Minority interest - - - - -
Net income 10.14M 5.45M 3.57M 7.52M 5.23M
Selling general administrative 12.86M 13.63M 14.49M 11.84M 10.37M
Selling and marketing expenses - - - - -
Gross profit 30.69M 24.71M 21.59M 26.68M 17.94M
Reconciled depreciation 2.95M 2.74M 2.59M 2.32M 2.30M
Ebit - - 2.29M 10.95M 3.84M
Ebitda - - 5.69M 13.11M 8.21M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 10.80M 6.17M 2.25M 10.86M 3.83M
Other operating expenses - - - - -
Interest expense 0.08M 0.05M 0.07M 0.09M 0.09M
Tax provision 3.76M 1.65M -0.54262M 3.17M 0.59M
Interest income 0.93M - 0.70M 0.05M 0.01M
Net interest income 0.85M -0.05122M 0.63M -0.03519M -0.07912M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - 3.17M 0.59M
Total revenue 50.81M 43.43M 40.45M 44.98M 32.69M
Total operating expenses - - - - -
Cost of revenue 20.12M 18.72M 18.86M 18.30M 14.75M
Total other income expense net 2.26M 0.98M 0.14M -0.13249M 2.07M
Discontinued operations - - - - -
Net income from continuing ops 10.14M 5.45M 3.57M 7.52M 5.23M
Net income applicable to common shares - - - 7.52M 5.23M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 64.77M 57.84M 54.07M 58.45M 51.38M
Intangible assets 10.81M 10.48M 11.11M 10.77M 8.72M
Earning assets - - - - -
Other current assets 0.53M 2.17M 1.22M 2.08M 1.81M
Total liab 16.88M 17.03M 16.38M 25.52M 29.60M
Total stockholder equity 47.90M 40.92M 37.69M 32.92M 21.78M
Deferred long term liab - - - - -
Other current liab - 0.11M 7.06M 8.93M 10.06M
Common stock - - - 36.15M 34.03M
Capital stock 37.76M 36.57M 36.32M 36.15M 34.03M
Retained earnings 5.76M 2.34M -0.16249M -3.25281M -10.80276M
Other liab - - - 6.67M 9.53M
Good will - - - - -
Other assets - - - 3.66M 5.80M
Cash 35.56M 30.12M 28.68M 30.60M 23.64M
Cash and equivalents - - - - -
Total current liabilities 13.34M 12.69M 12.17M 18.26M 18.93M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - 0.11M 0.12M 0.18M -
Short long term debt total - - - - -
Other stockholder equity - - - 0.03M -1.44031M
Property plant equipment - - - 2.02M 2.79M
Total current assets 50.30M 43.46M 38.78M 42.00M 34.07M
Long term investments - - - - -
Net tangible assets - - - 22.16M 13.06M
Short term investments - - - - -
Net receivables 12.81M 10.11M 8.86M 10.39M 9.69M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 1.52M 0.20M 0.19M 0.95M 1.79M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 14.47M 14.37M 15.28M 16.45M 17.31M
Capital lease obligations 0.47M 0.56M 0.26M 1.23M 1.74M
Long term debt total - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -2.24414M -1.11747M -1.68043M -3.53011M -2.62081M
Change to liabilities - - 0.00000M -2.13498M 14.36M
Total cashflows from investing activities - - - -3.53011M -2.62082M
Net borrowings - - - -0.64791M -0.79155M
Total cash from financing activities -3.79160M -3.21909M -0.89488M 0.76M -0.18358M
Change to operating activities - - - -0.63959M -0.53962M
Net income 10.14M 8.07M 3.57M 7.52M 5.23M
Change in cash 5.44M 1.45M -1.92118M 6.96M 13.31M
Begin period cash flow 30.12M 28.68M 30.60M 23.64M 10.33M
End period cash flow 35.56M 30.12M 28.68M 30.60M 23.64M
Total cash from operating activities - - - 9.73M 16.11M
Issuance of capital stock 1.15M 0.62M 0.18M 1.41M 0.61M
Depreciation - - 0.86M 1.23M 1.44M
Other cashflows from investing activities - - - 0.03M 0.64M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - -0.22605M -3.57135M
Sale purchase of stock -4.83707M -3.58702M -0.57052M - -
Other cashflows from financing activities - - - - -
Change to netincome - - 1.06M 2.32M -1.95025M
Capital expenditures 3.07M 1.89M 2.21M 0.42M 0.63M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow 8.40M 3.90M -1.55633M 6.16M 12.86M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
COGZF
Cogstate Limited		 - -% 1.89 25.00 23.09 4.68 6.04 4.93 15.34
VEEV
Veeva Systems Inc Class A		 -0.61 0.40% 152.69 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 8.55 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.17 3.38% 5.20 31.84 26.25 0.05 4.60 0.04 0.12
BTSG
BrightSpring Health Services, Inc. Common Stock		 0.96 1.46% 67.22 100.22 40.65 0.69 4.92 0.92 25.80

Reports Covered

Stock Research & News

View All

Profile

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer's disease and dementia, preclinical Alzheimer's disease, pediatrics and rare disease, Parkinson's disease, multiple sclerosis, schizophrenia, oncology, safety, and sleep and mood disorders. The company also designs and provides quality assurance services in clinical trials focused on the administration, scoring, and recording of conventional brain health assessments. In addition, it develops a tool for primary care physicians and/or hospitals to assess cognitive decline. Its technology and associated services are used to quantify the effect of disease and drugs, devices, or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The company serves biopharmaceutical companies, academic institutions, physicians, and patients. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

Cogstate Limited

367 Collins Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Bradley John O'Connor B.Bus, C.A., CA CEO, MD & Exec. Director NA
Prof. Paul Maruff BBSc (Hons), Ph.D. Founder & Chief Innovation Officer NA
Mr. Darren Watson Chief Financial Officer NA
Mr. Benjamin Bloomfield Chief Technology Officer NA
Mr. Kenneth Billard Chief Commercial Officer NA
Dr. Chris Edgar Ph.D. Chief Science Officer NA
Ms. Rachel Colite VP of Strategic Initiatives, Communication & People NA
Mr. David James Franks B.Ec, BEc, C.A., CA, F Fin, J.P., JP. Company Sec. 1970
Dr. Amy E. Veroff Ph.D. Principal Consultant NA
Mr. Bradley John O'Connor B.Bus, C.A. CEO, MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.